The N‐myc downstream regulated gene (NDRG) family: diverse functions, multiple applications

The N‐myc downstream regulated gene (NDRG) family of proteins consists of 4 members, NDRG1–4, which are well conserved through evolution. The first member to be discovered and responsible for the family name was NDRG1, because its expression is repressed by the proto‐oncogenes MYCN and MYC. All family members are characterized by an α/β hydrolase‐fold motif; however, the precise molecular and cellular function of these family members has not been fully elucidated. Although the exact function of NDRG family members has not been clearly elucidated, emerging evidence suggests that mutations in these genes are associated with diverse neurological and electrophysiological syndromes. In addition, aberrant expression as well as tumor suppressor and oncogenic functions affecting key hallmarks of carcinogenesis such as cell proliferation, differentiation, migration, invasion, and stress response have been reported for several of the NDRG proteins. In this review, we summarize the current literature on the NDRG family members concerning their structure, origin, and tissue distribution. In addition, we review the current knowledge regarding the regulation and signaling of the NDRG family members in development and normal physiology. Finally, their role in disease and potential clinical applications (their role as detection or prognostic markers) are discussed.—Melotte, V., Qu, X., Ongenaert, M., van Criekinge, W., de BruÏne, A. P., Baldwin, H. S., van Engeland, M. The N‐myc downstream regulated gene (NDRG) family: diverse functions, multiple applications. FASEB J. 24,4153–4166 (2010). www.fasebj.org

[1]  Pengyuan Yang,et al.  NDRG2 induced by oxidized LDL in macrophages antagonizes growth factor productions via selectively inhibiting ERK activation. , 2010, Biochimica et biophysica acta.

[2]  Andrew J. Wilson,et al.  Apoptotic sensitivity of colon cancer cells to histone deacetylase inhibitors is mediated by an Sp1/Sp3-activated transcriptional program involving immediate-early gene induction. , 2010, Cancer research.

[3]  Young Yang,et al.  Bone morphogenetic protein-4 induced by NDRG2 expression inhibits MMP-9 activity in breast cancer cells. , 2009, Biochemical and biophysical research communications.

[4]  Xiao-Fan Wang,et al.  NDRG4 Is Required for Cell Cycle Progression and Survival in Glioblastoma Cells* , 2009, The Journal of Biological Chemistry.

[5]  J. Herman,et al.  N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer. , 2009, Journal of the National Cancer Institute.

[6]  H. Izumi,et al.  N-myc downstream regulated gene 1/Cap43 suppresses tumor growth and angiogenesis of pancreatic cancer through attenuation of inhibitor of kappaB kinase beta expression. , 2009, Cancer research.

[7]  Young Yang,et al.  Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells. , 2009, Carcinogenesis.

[8]  Thomas Lumley,et al.  Common variants at ten loci influence QT interval duration in the QTGEN Study , 2009, Nature Genetics.

[9]  Wei Li,et al.  Decreased expression of NDRG1 in glioma is related to tumor progression and survival of patients , 2009, Journal of Neuro-Oncology.

[10]  Christian Gieger,et al.  Common variants at ten loci modulate the QT interval duration in the QTSCD Study , 2009, Nature Genetics.

[11]  T. Pawełczyk,et al.  Identification of High-Risk Stage II Colorectal Tumors by Combined Analysis of the NDRG1 Gene Expression and the Depth of Tumor Invasion , 2009, Annals of Surgical Oncology.

[12]  A. Andriulli,et al.  Promoter methylation correlates with reduced NDRG2 expression in advanced colon tumour , 2009, BMC Medical Genomics.

[13]  D. Cho,et al.  NDRG2 expression decreases with tumor stages and regulates TCF/β-catenin signaling in human colon carcinoma , 2009, Carcinogenesis.

[14]  Runsheng Li,et al.  NDRG3 is an androgen regulated and prostate enriched gene that promotes in vitro and in vivo prostate cancer cell growth , 2009, International journal of cancer.

[15]  M. Wolter,et al.  Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma , 2008, International journal of cancer.

[16]  D. Richardson,et al.  The iron-regulated metastasis suppressor, Ndrg-1: identification of novel molecular targets. , 2008, Biochimica et biophysica acta.

[17]  H. Yee,et al.  Regulation of hypoxia-inducible genes by ETS1 transcription factor. , 2008, Carcinogenesis.

[18]  Jianlin Yuan,et al.  Expression of NDRG2 in clear cell renal cell carcinoma. , 2008, Biological & pharmaceutical bulletin.

[19]  T. Kasamatsu,et al.  Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma. , 2008, Cancer letters.

[20]  In Young Park,et al.  Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis. , 2008, Cancer research.

[21]  T. Zhong,et al.  Ndrg4 is required for normal myocyte proliferation during early cardiac development in zebrafish. , 2008, Developmental biology.

[22]  S. So,et al.  N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells. , 2008, Cancer letters.

[23]  K. Shirouzu,et al.  Preclinical and clinical studies of novel breast cancer drugs targeting molecules involved in protein kinase C signaling, the putative metastasis-suppressor gene Cap43 and the Y-box binding protein-1. , 2008, Current medicinal chemistry.

[24]  T. Miyata,et al.  Differential Expression Patterns of NDRG Family Proteins in the Central Nervous System , 2008, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[25]  Hua Han,et al.  NDRG2 is a new HIF-1 Target Gene Necessary for Hypoxia-Induced Apoptosis in A549 Cells , 2008, Cellular Physiology and Biochemistry.

[26]  Kwang Dong Kim,et al.  Expression of human NDRG2 by myeloid dendritic cells inhibits down‐regulation of activated leukocyte cell adhesion molecule (ALCAM) and contributes to maintenance of T cell stimulatory activity , 2008, Journal of leukocyte biology.

[27]  Young Yang,et al.  Expression of NDRG2 is related to tumor progression and survival of gastric cancer patients through Fas-mediated cell death , 2007, Experimental & Molecular Medicine.

[28]  Young Yang,et al.  SOCS1 induced by NDRG2 expression negatively regulates STAT3 activation in breast cancer cells. , 2007, Biochemical and biophysical research communications.

[29]  H. Jung,et al.  Microarray analysis of normal cervix, carcinoma in situ, and invasive cervical cancer: identification of candidate genes in pathogenesis of invasion in cervical cancer , 2007, International Journal of Gynecologic Cancer.

[30]  Rodrigo Lopez,et al.  Clustal W and Clustal X version 2.0 , 2007, Bioinform..

[31]  G. Hoff,et al.  Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma , 2007, BMC Cancer.

[32]  K. Tchou-Wong,et al.  Egr-1 mediates hypoxia-inducible transcription of the NDRG1 gene through an overlapping Egr-1/Sp1 binding site in the promoter. , 2007, Cancer research.

[33]  N. Farman,et al.  (NDRG2) Stimulates Amiloride-sensitive Na+ Currents in Xenopus laevis Oocytes and Fisher Rat Thyroid Cells* , 2007, Journal of Biological Chemistry.

[34]  Å. Borg,et al.  The Wilms' tumor gene 1 (WT1) induces expression of the N-myc downstream regulated gene 2 (NDRG2). , 2007, DNA and cell biology.

[35]  Hua Han,et al.  Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines. , 2007, Biochemical and biophysical research communications.

[36]  A. Llombart‐Bosch,et al.  Array comparative genomic hybridization analysis of chromosomal imbalances and their target genes in gastrointestinal stromal tumors , 2007, Genes, chromosomes & cancer.

[37]  T. Moon,et al.  Impaired Mast Cell Maturation and Degranulation and Attenuated Allergic Responses in Ndrg1-Deficient Mice1 , 2007, The Journal of Immunology.

[38]  K. Kumamoto,et al.  Correlation of N-myc downstream-regulated gene 1 expression with clinical outcomes of colorectal cancer patients of different race/ethnicity. , 2007, World journal of gastroenterology.

[39]  J. Herman,et al.  Identification of epigenetically silenced genes in tumor endothelial cells. , 2007, Cancer research.

[40]  Hua Han,et al.  The Repression of Human Differentiation-related Gene NDRG2 Expression by Myc via Miz-1-dependent Interaction with the NDRG2 Core Promoter* , 2006, Journal of Biological Chemistry.

[41]  Tsonwin Hai,et al.  The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer. , 2006, Cancer research.

[42]  R. Lothe,et al.  ADAMTS1, CRABP1, and NR3C1 Identified as Epigenetically Deregulated Genes in Colorectal Tumorigenesis , 2006, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[43]  G. Parmigiani,et al.  The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.

[44]  W. Sterry,et al.  Identification of dysregulated genes in cutaneous squamous cell carcinoma. , 2006, Oncology reports.

[45]  R. Weimann,et al.  Cellular differentiation determines the expression of the hypoxia-inducible protein NDRG1 in pancreatic cancer , 2006, British Journal of Cancer.

[46]  D. Ross,et al.  Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  M. Kuwano,et al.  Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis. , 2006, Cancer research.

[48]  Keiko Takahashi,et al.  Ndrg4 enhances NGF‐induced ERK activation uncoupled with Elk‐1 activation , 2006, Journal of cellular biochemistry.

[49]  Y. Fujii,et al.  Decreased expression of NDRG1 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma. , 2006, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[50]  Lan Shen,et al.  Expression analysis of the NDRG2 gene in mouse embryonic and adult tissues , 2006, Cell and Tissue Research.

[51]  Y. Sadovsky,et al.  N-Myc Down-regulated Gene 1 Modulates the Response of Term Human Trophoblasts to Hypoxic Injury* , 2006, Journal of Biological Chemistry.

[52]  K. Honda,et al.  Ndrg2 promotes neurite outgrowth of NGF-differentiated PC12 cells , 2005, Neuroscience Letters.

[53]  Arie Perry,et al.  Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. , 2005, Cancer research.

[54]  G. Watts,et al.  NDRG1 interacts with APO A-I and A-II and is a functional candidate for the HDL-C QTL on 8q24. , 2005, Biochemical and biophysical research communications.

[55]  Hung-Ming Wang,et al.  Identification of differentially expressed genes in oral squamous cell carcinoma (OSCC): Overexpression of NPM, CDK1 and NDRG1 and underexpression of CHES1 , 2005, International journal of cancer.

[56]  C. Cordon-Cardo,et al.  Drg1 Expression in 131 Colorectal Liver Metastases: Correlation with Clinical Variables and Patient Outcomes , 2005, Clinical Cancer Research.

[57]  N. Bye,et al.  Glucocorticoid regulation of glial responses during hippocampal neurodegeneration and regeneration , 2005, Brain Research Reviews.

[58]  Y. Sadovsky,et al.  Microarray-based identification of differentially expressed genes in hypoxic term human trophoblasts and in placental villi of pregnancies with growth restricted fetuses. , 2005, Placenta.

[59]  P. Cohen,et al.  Exploitation of KESTREL to identify NDRG family members as physiological substrates for SGK1 and GSK3. , 2004, The Biochemical journal.

[60]  Yanchun Deng,et al.  NDRG2 expression and mutation in human liver and pancreatic cancers. , 2004, World journal of gastroenterology.

[61]  M. Westfall,et al.  NDRG1 Is Necessary for p53-dependent Apoptosis* , 2004, Journal of Biological Chemistry.

[62]  D. Richardson,et al.  Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation. , 2004, Blood.

[63]  U. Suter,et al.  Expression analysis of the N-Myc downstream-regulated gene 1 indicates that myelinating Schwann cells are the primary disease target in hereditary motor and sensory neuropathy-Lom , 2004, Neurobiology of Disease.

[64]  Ying Wang,et al.  PTEN Up-Regulates the Tumor Metastasis Suppressor Gene Drg-1 in Prostate and Breast Cancer , 2004, Cancer Research.

[65]  Hakan Cangul,et al.  Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers , 2004, BMC Genetics.

[66]  M. Kuwano,et al.  N‐myc downstream‐regulated gene 1 expression in injured sciatic nerves , 2004, Glia.

[67]  Ken Saito,et al.  Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression , 2004, Oncogene.

[68]  J. Troncoso,et al.  NDRG2: a novel Alzheimer's disease associated protein , 2004, Neurobiology of Disease.

[69]  M. Murakami,et al.  N-myc downregulated gene 1 is a phosphorylated protein in mast cells. , 2004, Biological & pharmaceutical bulletin.

[70]  M. Murakami,et al.  Association of N-myc downregulated gene 1 with heat-shock cognate protein 70 in mast cells. , 2004, Biological & pharmaceutical bulletin.

[71]  T. Miyata,et al.  Ndrg1-Deficient Mice Exhibit a Progressive Demyelinating Disorder of Peripheral Nerves , 2004, Molecular and Cellular Biology.

[72]  G. Corthals,et al.  Akt Mediates Insulin-stimulated Phosphorylation of Ndrg2 , 2004, Journal of Biological Chemistry.

[73]  Kwang Dong Kim,et al.  Expression and regulation of NDRG2 (N‐myc downstream regulated gene 2) during the differentiation of dendritic cells , 2003, FEBS letters.

[74]  A. Fukui,et al.  Identification and characterization of Xenopus NDRG1. , 2003, Biochemical and biophysical research communications.

[75]  S. Leung,et al.  N‐Myc downstream‐regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation , 2003, International journal of cancer.

[76]  L. Kretzner,et al.  The growth-inhibitory Ndrg1 gene is a Myc negative target in human neuroblastomas and other cell types with overexpressed N- or c-myc , 2003, Molecular and Cellular Biochemistry.

[77]  T. Shuin,et al.  Downregulation of Cap43 gene by von Hippel‐Lindau tumor suppressor protein in human renal cancer cells , 2003, International journal of cancer.

[78]  T. Moon,et al.  Identification of NDRG1 as an early inducible gene during in vitro maturation of cultured mast cells. , 2003, Biochemical and biophysical research communications.

[79]  K. Miura,et al.  The Drg-1 gene suppresses tumor metastasis in prostate cancer. , 2003, Cancer research.

[80]  Calum A. MacRae,et al.  Drugs That Induce Repolarization Abnormalities Cause Bradycardia in Zebrafish , 2003, Circulation.

[81]  R. Sowdhamini,et al.  Fold prediction and comparative modeling of Bdm1: a probable α/β hydrolase associated with hot water epilepsy , 2003 .

[82]  N. Farman,et al.  Characterization of Rat NDRG2 (N-Myc Downstream Regulated Gene 2), a Novel Early Mineralocorticoid-specific Induced Gene* , 2002, The Journal of Biological Chemistry.

[83]  L. McCue,et al.  Identification of a novel class in the α/β hydrolase fold superfamily: The N‐myc differentiation‐related proteins , 2002 .

[84]  M. Takeda,et al.  Inhibition of neurite outgrowth by reduced level of NDRG4 protein in antisense transfected PC12 cells. , 2002, Brain research. Developmental brain research.

[85]  M. Blagosklonny,et al.  The Regulation of Hypoxic Genes by Calcium Involves c-Jun/AP-1, Which Cooperates with Hypoxia-Inducible Factor 1 in Response to Hypoxia , 2002, Molecular and Cellular Biology.

[86]  Yusuke Nakamura,et al.  Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway , 2001, Oncogene.

[87]  K. Ying,et al.  Cloning and expression pattern of the human NDRG3 gene. , 2001, Biochimica et biophysica acta.

[88]  T. Miyata,et al.  Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart. , 2001, Genomics.

[89]  C. Graham,et al.  Hypoxia induces the expression of a 43-kDa protein (PROXY-1) in normal and malignant cells. , 2000, Biochemical and biophysical research communications.

[90]  P K Thomas,et al.  N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom. , 2000, American journal of human genetics.

[91]  H. Ford,et al.  Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. , 2000, Cancer research.

[92]  H. Kondoh,et al.  Identification of new genes ndr2 and ndr3 which are related to Ndr1/RTP/Drg1 but show distinct tissue specificity and response to N-myc. , 1999, Biochemical and biophysical research communications.

[93]  L. Lin,et al.  Identification of a stress-induced protein during human trophoblast differentiation by differential display analysis. , 1999, Biology of reproduction.

[94]  J. Swinnen,et al.  The differentiation‐related gene 1, Drg1, is markedly upregulated by androgens in LNCaP prostatic adenocarcinoma cells , 1999, FEBS letters.

[95]  C. Wykoff,et al.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.

[96]  H. Kondoh,et al.  N-myc-dependent repression of Ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant , 1999, Mechanisms of Development.

[97]  S. Aaronson,et al.  Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. , 1998, Cancer research.

[98]  K. Salnikow,et al.  Cap43, a novel gene specifically induced by Ni2+ compounds. , 1998, Cancer research.

[99]  W. Dinjens,et al.  A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[100]  T. Miyata,et al.  Homocysteine-respondent Genes in Vascular Endothelial Cells Identified by Differential Display Analysis , 1996, The Journal of Biological Chemistry.

[101]  Roderic D. M. Page,et al.  TreeView: an application to display phylogenetic trees on personal computers , 1996, Comput. Appl. Biosci..

[102]  M. Frommer,et al.  CpG islands in vertebrate genomes. , 1987, Journal of molecular biology.

[103]  J. Lim,et al.  NDRG2 suppresses cell proliferation through down‐regulation of AP‐1 activity in human colon carcinoma cells , 2009, International journal of cancer.

[104]  M. Kuwano,et al.  N-myc downstream regulated gene 1 (NDRG1)/Cap43 enhances portal vein invasion and intrahepatic metastasis in human hepatocellular carcinoma. , 2008, Oncology reports.

[105]  D. Ross,et al.  Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma , 2007, Modern Pathology.

[106]  Michel Schneider,et al.  UniProtKB/Swiss-Prot. , 2007, Methods in molecular biology.

[107]  Fuchu He,et al.  Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family , 2004, Molecular and Cellular Biochemistry.

[108]  V. Han,et al.  Reducing agent and tunicamycin-responsive protein (RTP) mRNA expression in the placentae of normal and pre-eclamptic women. , 2004, Placenta.

[109]  R. Sowdhamini,et al.  Fold prediction and comparative modeling of Bdm1: a probable alpha/beta hydrolase associated with hot water epilepsy. , 2003, Journal of molecular modeling.

[110]  C. Lawrence,et al.  Identification of a novel class in the alpha/beta hydrolase fold superfamily: the N-myc differentiation-related proteins. , 2002, Proteins.

[111]  M. Blagosklonny,et al.  Carcinogenic nickel induces genes involved with hypoxic stress. , 2000, Cancer research.